CEQ-508

N/A

Report date: 2022/10/23 13:38:05
NME

Base Information

Drug NameCEQ-508
Drug Alias NameTkRNAis (Marina)TkRNAis (Cequent)CEQ-508
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionRNA interferenceCatenin beta 1 inhibitorsWnt signalling pathway inhibitors
TargetsCatenin beta 1
Therapy Area/IndicationsAdenomatous Polyposis Coli
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMarina Biotech
China Registration ClassN/A

Develop Information

Active CompaniesMarina Biotech
Inactive CompaniesN/A
Active IndicationsAdenomatous Polyposis Coli
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A